Biomarkers in feces could replace colonoscopies

Thanks to research perform by veterinarians, unpleasant colonoscopies could possibly be relegated to the barbaric past. University of Missouri researchers, including those at the College of Veterinary Medicine, have discovered biomarkers in mouse feces that predicted inflammation-associated colon cancer. The hope is that feces screening could replace colonoscopies in the future. "Many people put off colonoscopies longer than they should because of the invasiveness and unpleasant nature of the exam, and it's not pleasant for mice either," Aaron Ericsson, a post-doctoral researcher at MU, told DVM Newsmagazine. "That unpleasantness is negated with this test." (Of course, this study follows previous development of a stool-based DNA test for colon cancer at Exact Sciences.) Story

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.